$PAHC
Phibro Animal Health Corp

2024 Q3 Form 10-Q Financial Statement

#000155837024014644 Filed on November 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $260.4M
YoY Change 12.57%
Cost Of Revenue $176.9M
YoY Change 8.14%
Gross Profit $83.50M
YoY Change 23.28%
Gross Profit Margin 32.06%
Selling, General & Admin $65.80M
YoY Change -3.88%
% of Gross Profit 78.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.004M
YoY Change 1.5%
% of Gross Profit 10.78%
Operating Expenses $65.80M
YoY Change -3.88%
Operating Profit $17.70M
YoY Change -2537.88%
Interest Expense -$7.641M
YoY Change -235.36%
% of Operating Profit -43.17%
Other Income/Expense, Net
YoY Change
Pretax Income $9.620M
YoY Change -180.31%
Income Tax $2.645M
% Of Pretax Income 27.49%
Net Earnings $6.975M
YoY Change -187.02%
Net Earnings / Revenue 2.68%
Basic Earnings Per Share $0.17
Diluted Earnings Per Share $0.17
COMMON SHARES
Basic Shares Outstanding 40.50M
Diluted Shares Outstanding 40.58M

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $89.84M
YoY Change -1.49%
Cash & Equivalents $51.84M
Short-Term Investments $38.00M
Other Short-Term Assets $47.60M
YoY Change -26.65%
Inventory $272.6M
Prepaid Expenses
Receivables $160.8M
Other Receivables $0.00
Total Short-Term Assets $570.8M
YoY Change -2.34%
LONG-TERM ASSETS
Property, Plant & Equipment $206.3M
YoY Change 6.7%
Goodwill $54.59M
YoY Change 2.51%
Intangibles
YoY Change
Long-Term Investments $5.453M
YoY Change -6.21%
Other Assets $91.68M
YoY Change 12.77%
Total Long-Term Assets $395.5M
YoY Change 4.06%
TOTAL ASSETS
Total Short-Term Assets $570.8M
Total Long-Term Assets $395.5M
Total Assets $966.3M
YoY Change 0.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $86.53M
YoY Change 12.06%
Accrued Expenses $42.49M
YoY Change 16.42%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $7.500M
YoY Change -68.94%
Total Short-Term Liabilities $176.9M
YoY Change 2.63%
LONG-TERM LIABILITIES
Long-Term Debt $287.7M
YoY Change -5.6%
Other Long-Term Liabilities $64.20M
YoY Change 6.32%
Total Long-Term Liabilities $351.9M
YoY Change -3.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $176.9M
Total Long-Term Liabilities $351.9M
Total Liabilities $707.8M
YoY Change 2.36%
SHAREHOLDERS EQUITY
Retained Earnings $246.0M
YoY Change -0.82%
Common Stock $136.5M
YoY Change 0.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $258.5M
YoY Change
Total Liabilities & Shareholders Equity $966.3M
YoY Change 0.18%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income $6.975M
YoY Change -187.02%
Depreciation, Depletion And Amortization $9.004M
YoY Change 1.5%
Cash From Operating Activities $12.62M
YoY Change -22.08%
INVESTING ACTIVITIES
Capital Expenditures $9.583M
YoY Change 28.11%
Acquisitions
YoY Change
Other Investing Activities -$653.0K
YoY Change 426.61%
Cash From Investing Activities -$2.930M
YoY Change -80.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -29.20M
YoY Change -2352.85%
NET CHANGE
Cash From Operating Activities 12.62M
Cash From Investing Activities -2.930M
Cash From Financing Activities -29.20M
Net Change In Cash -18.78M
YoY Change -1102.99%
FREE CASH FLOW
Cash From Operating Activities $12.62M
Capital Expenditures $9.583M
Free Cash Flow $3.039M
YoY Change -65.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.pahc.com/20240930#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2024Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001069899
CY2024Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q3 dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2024Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q3 us-gaap Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q2 us-gaap Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration
EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://www.pahc.com/20240930#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2024Q3 us-gaap Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration
EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://www.pahc.com/20240930#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2024Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
CY2024Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
CY2024Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2024Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.pahc.com/20240930#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2024Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q2 us-gaap Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q3 dei Document Type
DocumentType
10-Q
CY2024Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q3 dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2024Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q3 dei Entity File Number
EntityFileNumber
001-36410
CY2024Q3 dei Entity Registrant Name
EntityRegistrantName
Phibro Animal Health Corporation
CY2024Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-1840497
CY2024Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
Glenpointe Centre East, 3rd Floor
CY2024Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
300 Frank W. Burr Boulevard
CY2024Q3 dei Entity Address Address Line3
EntityAddressAddressLine3
Suite 21
CY2024Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Teaneck
CY2024Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2024Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07666-6712
CY2024Q3 dei City Area Code
CityAreaCode
201
CY2024Q3 dei Local Phone Number
LocalPhoneNumber
329-7300
CY2024Q3 dei Security12b Title
Security12bTitle
Class A Common Stock, $0.0001 par value per share
CY2024Q3 dei Trading Symbol
TradingSymbol
PAHC
CY2024Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2024Q3 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q3 dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
260432000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
231349000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
176937000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
163623000
CY2024Q3 us-gaap Gross Profit
GrossProfit
83495000
CY2023Q3 us-gaap Gross Profit
GrossProfit
67726000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
65796000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
68452000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
17699000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-726000
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-7641000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4564000
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-438000
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-6689000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9620000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11979000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2645000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3964000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
6975000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-8015000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40504000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40504000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40582000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
6975000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-8015000
CY2024Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
-4848000
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
-1891000
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
3168000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-3560000
CY2023Q3 us-gaap Other Comprehensive Income Loss Finalization Of Pension And Non Pension Postretirement Plan Valuation Before Tax
OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
10425000
CY2024Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
78000
CY2023Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
644000
CY2024Q3 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-1194000
CY2023Q3 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
2264000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-408000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3354000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6567000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4661000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51837000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70613000
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
38000000
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
44000000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
160777000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
169452000
CY2024Q3 us-gaap Inventory Net
InventoryNet
272556000
CY2024Q2 us-gaap Inventory Net
InventoryNet
265911000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
47597000
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
51021000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
570767000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
600997000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
206315000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
203300000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
42935000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
45033000
CY2024Q3 us-gaap Goodwill
Goodwill
54588000
CY2024Q2 us-gaap Goodwill
Goodwill
54557000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
91684000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
78297000
CY2024Q3 us-gaap Assets
Assets
966289000
CY2024Q2 us-gaap Assets
Assets
982184000
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
7500000
CY2024Q2 us-gaap Loans Payable Current
LoansPayableCurrent
29795000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
86528000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
85567000
CY2024Q3 pahc Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
82866000
CY2024Q2 pahc Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
88786000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
176894000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
204148000
CY2024Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
179000000
CY2024Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
176000000
CY2024Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
287668000
CY2024Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
282289000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
64200000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
63106000
CY2024Q3 us-gaap Liabilities
Liabilities
707762000
CY2024Q2 us-gaap Liabilities
Liabilities
725543000
CY2024Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
4000
CY2024Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
4000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
16000000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
16000000
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
136457000
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
136278000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
246001000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
243886000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-123935000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-123527000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
258527000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
256641000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
966289000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
982184000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
6975000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-8015000
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9004000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8871000
CY2024Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
367000
CY2023Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
260000
CY2024Q3 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-4883000
CY2023Q3 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-2691000
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
517000
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-3222000
CY2023Q3 us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
10425000
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
179000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
81000
CY2024Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
461000
CY2023Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-959000
CY2024Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9208000
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-12781000
CY2024Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5164000
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5005000
CY2024Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
979000
CY2023Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3297000
CY2024Q3 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1113000
CY2023Q3 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
191000
CY2024Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1304000
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4603000
CY2024Q3 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3524000
CY2023Q3 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-5804000
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12622000
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16199000
CY2023Q3 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
17000000
CY2024Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
6000000
CY2023Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
9000000
CY2024Q3 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
9583000
CY2023Q3 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
7476000
CY2024Q3 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-653000
CY2023Q3 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-124000
CY2024Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2930000
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15352000
CY2024Q3 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
267000000
CY2023Q3 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
51000000
CY2024Q3 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
264000000
CY2023Q3 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
38000000
CY2024Q3 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
300000000
CY2024Q3 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
315015000
CY2023Q3 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
5105000
CY2024Q3 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
10377000
CY2024Q3 pahc Payments For Insurance Premium Financing Financing Activities
PaymentsForInsurancePremiumFinancingFinancingActivities
1945000
CY2023Q3 pahc Payments For Insurance Premium Financing Financing Activities
PaymentsForInsurancePremiumFinancingFinancingActivities
1739000
CY2024Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4860000
CY2023Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4860000
CY2024Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29197000
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1296000
CY2024Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
729000
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-271000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-18776000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1872000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70613000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41281000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51837000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43153000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
256641000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6567000
CY2024Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2024Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4860000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
179000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
258527000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
282509000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4661000
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4860000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
81000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
273069000
CY2024Q3 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">1.  Description of Business</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Phibro Animal Health Corporation (“Phibro” or “PAHC”) and its subsidiaries (together, the “Company”) is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture and dogs. The Company is also a manufacturer and marketer of performance products for use in the personal care, industrial chemical and chemical catalyst industries. Unless otherwise indicated or the context requires otherwise, references in this report to “we,” “our,” “us,” and similar expressions refer to Phibro and its subsidiaries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The unaudited consolidated financial information for the three months ended September 30, 2024 and 2023, is presented on the same basis as the financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024 (the “Annual Report”), filed with the Securities and Exchange Commission on August 28, 2024 (File no. 001-36410). In the opinion of management, these financial statements include all adjustments necessary for a fair statement of the financial position, results of operations and cash flows of the Company for the interim periods, and the adjustments are of a normal and recurring nature. The financial results for any interim period are not necessarily indicative of the results for the full year. The consolidated balance sheet information as of June 30, 2024, was derived from the audited consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). The unaudited consolidated financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The consolidated financial statements include the accounts of Phibro and its consolidated subsidiaries. Intercompany balances and transactions have been eliminated from the consolidated financial statements. The decision to consolidate an entity requires consideration of majority voting interests, as well as effective control over the entity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p>
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
6975000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6975000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8015000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8015000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40504000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40504000
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
78000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40582000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2024Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2023Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2024Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
260432000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
231349000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
260432000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
231349000
CY2024Q3 pahc Payment Term Low End Of Range
PaymentTermLowEndOfRange
P30D
CY2024Q3 pahc Payment Term High End Of Range
PaymentTermHighEndOfRange
P120D
CY2024Q3 pahc Average Customer Collection Period
AverageCustomerCollectionPeriod
P60D
CY2024Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
367000
CY2023Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
260000
CY2024Q3 pahc Debt Instrument Refinancing Costs
DebtInstrumentRefinancingCosts
1960000
CY2024Q3 us-gaap Interest Expense Other
InterestExpenseOther
226000
CY2023Q3 us-gaap Interest Expense Other
InterestExpenseOther
68000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
8765000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
5645000
CY2024Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
1124000
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
1081000
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-7641000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4564000
CY2024Q3 pahc Debt Instrument Refinancing Costs New Creditor And Third Party Financing
DebtInstrumentRefinancingCostsNewCreditorAndThirdPartyFinancing
1446000
CY2024Q3 pahc Debt Instrument Refinancing Costs Debt Extinguishment
DebtInstrumentRefinancingCostsDebtExtinguishment
514000
CY2024Q3 us-gaap Depreciation
Depreciation
6742000
CY2023Q3 us-gaap Depreciation
Depreciation
6431000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2262000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2440000
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9004000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8871000
CY2023Q3 pahc Defined Benefit Plan Settlement Annuity Purchase Agreement Benefit Obligation Annuity Purchase Price
DefinedBenefitPlanSettlementAnnuityPurchaseAgreementBenefitObligationAnnuityPurchasePrice
26381000
CY2023Q3 us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
10425000
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
76795000
CY2024Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
72799000
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
25040000
CY2024Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
23550000
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
170721000
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
169562000
CY2024Q3 us-gaap Inventory Net
InventoryNet
272556000
CY2024Q2 us-gaap Inventory Net
InventoryNet
265911000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
37559000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
37604000
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
25526000
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
19371000
CY2024Q3 us-gaap Deposits Assets
DepositsAssets
623000
CY2024Q2 us-gaap Deposits Assets
DepositsAssets
1646000
CY2024Q3 us-gaap Other Investments
OtherInvestments
6395000
CY2024Q2 us-gaap Other Investments
OtherInvestments
6305000
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
5453000
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
5183000
CY2024Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
8844000
CY2024Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
911000
CY2024Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
7284000
CY2024Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
7277000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
91684000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
78297000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
29979000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
37612000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7897000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7460000
CY2024Q3 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
4617000
CY2024Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
7875000
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
11911000
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
8918000
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
5543000
CY2024Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
2931000
CY2024Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1484000
CY2024Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1265000
CY2024Q3 pahc Accrued Insurance Premium Financing Current
AccruedInsurancePremiumFinancingCurrent
3241000
CY2024Q2 pahc Accrued Insurance Premium Financing Current
AccruedInsurancePremiumFinancingCurrent
5185000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
18194000
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
17540000
CY2024Q3 pahc Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
82866000
CY2024Q2 pahc Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
88786000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29819000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29915000
CY2024Q3 pahc Long Term And Deferred Income Taxes
LongTermAndDeferredIncomeTaxes
15036000
CY2024Q2 pahc Long Term And Deferred Income Taxes
LongTermAndDeferredIncomeTaxes
14218000
CY2024Q3 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
6749000
CY2024Q2 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
6678000
CY2024Q3 us-gaap Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Projected Benefit Obligation
DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation
2210000
CY2024Q2 us-gaap Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Projected Benefit Obligation
DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation
2237000
CY2024Q3 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
3240000
CY2024Q2 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
3212000
CY2024Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
653000
CY2024Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
6493000
CY2024Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
6846000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
64200000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
63106000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-123935000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-123527000
CY2024Q3 pahc Debt Instrument Refinancing Costs
DebtInstrumentRefinancingCosts
1960000
CY2024Q3 pahc Debt Instrument Refinancing Costs New Creditor And Third Party Financing
DebtInstrumentRefinancingCostsNewCreditorAndThirdPartyFinancing
1446000
CY2024Q3 pahc Debt Instrument Refinancing Costs Debt Extinguishment
DebtInstrumentRefinancingCostsDebtExtinguishment
514000
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
298125000
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
313140000
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2957000
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1056000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
295168000
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
312084000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
7500000
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
29795000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
287668000
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
282289000
us-gaap Payments For Environmental Liabilities
PaymentsForEnvironmentalLiabilities
5019000
CY2024Q3 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
4273000
CY2024Q2 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
4282000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
176937000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
163623000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
65796000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
68452000
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-7641000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4564000
CY2024 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2024 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
260432000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
231349000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9620000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11979000
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-7641000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4564000
CY2024Q3 pahc Corporate Costs
CorporateCosts
15779000
CY2023Q3 pahc Corporate Costs
CorporateCosts
14133000
CY2024Q3 pahc Acquisition Related Transaction Costs
AcquisitionRelatedTransactionCosts
3424000
CY2023Q3 us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
10425000
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-438000
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-6689000
CY2024Q3 pahc Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
46435000
CY2023Q3 pahc Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
32784000
CY2024Q3 us-gaap Assets
Assets
966289000
CY2024Q2 us-gaap Assets
Assets
982184000
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001558370-24-014644-index-headers.html Edgar Link pending
0001558370-24-014644-index.html Edgar Link pending
0001558370-24-014644.txt Edgar Link pending
0001558370-24-014644-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pahc-20240930.xsd Edgar Link pending
pahc-20240930x10q.htm Edgar Link pending
pahc-20240930xex31d1.htm Edgar Link pending
pahc-20240930xex31d2.htm Edgar Link pending
pahc-20240930xex32d1.htm Edgar Link pending
pahc-20240930xex32d2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
pahc-20240930_cal.xml Edgar Link unprocessable
pahc-20240930_def.xml Edgar Link unprocessable
pahc-20240930_lab.xml Edgar Link unprocessable
pahc-20240930_pre.xml Edgar Link unprocessable
pahc-20240930x10q_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending